DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kantarjian HM, DeAngelo DJ, Stelljes M. et al.
Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia.
N Engl J Med 2016;
375 (08) 740-753
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.